ZOLL Announces Five-Year Study Confirming Safety, Efficacy and Beneficial Effects of Long-Term Transvenous Phrenic Nerve Stimulation (the Remedē System)

Monday, May 17, 2021 in Chelmsford, Mass.

ZOLL Medical Receives FDA IDE Approval for Initiation of ISO SHOCK (Incorporating Supersaturated Oxygen in Shock) Feasibility Study

Thursday, May 13, 2021 in Chelmsford, Mass.

ZOLL Medical Corporation Acquires Respicardia, Inc

Monday, April 12, 2021 in Chelmsford, Mass.

Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care

Tuesday, March 9, 2021 in Chelmsford, Mass.

ZOLL Medical's Advanced Defibrillators Win Five-star World Of Safety And Health Asia Award 2020

Wednesday, January 6, 2021 in Chelmsford, Mass.

ZOLL Foundation Grants to Nearly 70 Recipients in Resuscitation and Critical Care Research Surpass $2.5 Million

Wednesday, January 27, 2021 in Chelmsford, Mass.